Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics

Research Group

Breast and Gynecologic Cancer

Expiration Date

Thu, January 7, 2027: 12:00p.m. UTC

Program Official

Type of Funding Opportunity

PAR

Clinical Trials Status

Clinical Trial Not Allowed

Announcement Number And URL

Activity Code

R21

NOFO Research Area

Prevention